Global Glioblastoma Multiforme Treatment (GBM) Market Research Report 2023

Report ID: 1991159 | Published Date: Sep 2024 | No. of Page: 88 | Base Year: 2023 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Glioblastoma Multiforme Treatment (GBM) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Chemotherapy
        1.2.3 Radiotherapy
        1.2.4 Gene therapy
        1.2.5 Molecular biotechnology
    1.3 Market by Application
        1.3.1 Global Glioblastoma Multiforme Treatment (GBM) Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital & Clinic
        1.3.3 ASCs
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Glioblastoma Multiforme Treatment (GBM) Market Perspective (2017-2028)
    2.2 Glioblastoma Multiforme Treatment (GBM) Growth Trends by Region
        2.2.1 Glioblastoma Multiforme Treatment (GBM) Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Glioblastoma Multiforme Treatment (GBM) Historic Market Size by Region (2017-2022)
        2.2.3 Glioblastoma Multiforme Treatment (GBM) Forecasted Market Size by Region (2023-2028)
    2.3 Glioblastoma Multiforme Treatment (GBM) Market Dynamics
        2.3.1 Glioblastoma Multiforme Treatment (GBM) Industry Trends
        2.3.2 Glioblastoma Multiforme Treatment (GBM) Market Drivers
        2.3.3 Glioblastoma Multiforme Treatment (GBM) Market Challenges
        2.3.4 Glioblastoma Multiforme Treatment (GBM) Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Glioblastoma Multiforme Treatment (GBM) Players by Revenue
        3.1.1 Global Top Glioblastoma Multiforme Treatment (GBM) Players by Revenue (2017-2022)
        3.1.2 Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Players (2017-2022)
    3.2 Global Glioblastoma Multiforme Treatment (GBM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Glioblastoma Multiforme Treatment (GBM) Revenue
    3.4 Global Glioblastoma Multiforme Treatment (GBM) Market Concentration Ratio
        3.4.1 Global Glioblastoma Multiforme Treatment (GBM) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Glioblastoma Multiforme Treatment (GBM) Revenue in 2021
    3.5 Glioblastoma Multiforme Treatment (GBM) Key Players Head office and Area Served
    3.6 Key Players Glioblastoma Multiforme Treatment (GBM) Product Solution and Service
    3.7 Date of Enter into Glioblastoma Multiforme Treatment (GBM) Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Glioblastoma Multiforme Treatment (GBM) Breakdown Data by Type
    4.1 Global Glioblastoma Multiforme Treatment (GBM) Historic Market Size by Type (2017-2022)
    4.2 Global Glioblastoma Multiforme Treatment (GBM) Forecasted Market Size by Type (2023-2028)
5 Glioblastoma Multiforme Treatment (GBM) Breakdown Data by Application
    5.1 Global Glioblastoma Multiforme Treatment (GBM) Historic Market Size by Application (2017-2022)
    5.2 Global Glioblastoma Multiforme Treatment (GBM) Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Glioblastoma Multiforme Treatment (GBM) Market Size (2017-2028)
    6.2 North America Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2017-2022)
    6.3 North America Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Glioblastoma Multiforme Treatment (GBM) Market Size (2017-2028)
    7.2 Europe Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2017-2022)
    7.3 Europe Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Market Size (2017-2028)
    8.2 Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2017-2022)
    8.3 Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Glioblastoma Multiforme Treatment (GBM) Market Size (2017-2028)
    9.2 Latin America Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2017-2022)
    9.3 Latin America Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Market Size (2017-2028)
    10.2 Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2017-2022)
    10.3 Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Merck
        11.1.1 Merck Company Detail
        11.1.2 Merck Business Overview
        11.1.3 Merck Glioblastoma Multiforme Treatment (GBM) Introduction
        11.1.4 Merck Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2017-2022)
        11.1.5 Merck Recent Development
    11.2 Teva Pharmaceutical
        11.2.1 Teva Pharmaceutical Company Detail
        11.2.2 Teva Pharmaceutical Business Overview
        11.2.3 Teva Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Introduction
        11.2.4 Teva Pharmaceutical Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2017-2022)
        11.2.5 Teva Pharmaceutical Recent Development
    11.3 Arbor Pharmaceuticals
        11.3.1 Arbor Pharmaceuticals Company Detail
        11.3.2 Arbor Pharmaceuticals Business Overview
        11.3.3 Arbor Pharmaceuticals Glioblastoma Multiforme Treatment (GBM) Introduction
        11.3.4 Arbor Pharmaceuticals Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2017-2022)
        11.3.5 Arbor Pharmaceuticals Recent Development
    11.4 Sun Pharmaceutical
        11.4.1 Sun Pharmaceutical Company Detail
        11.4.2 Sun Pharmaceutical Business Overview
        11.4.3 Sun Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Introduction
        11.4.4 Sun Pharmaceutical Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2017-2022)
        11.4.5 Sun Pharmaceutical Recent Development
    11.5 Roche
        11.5.1 Roche Company Detail
        11.5.2 Roche Business Overview
        11.5.3 Roche Glioblastoma Multiforme Treatment (GBM) Introduction
        11.5.4 Roche Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2017-2022)
        11.5.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Glioblastoma Multiforme Treatment (GBM) Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Chemotherapy
    Table 3. Key Players of Radiotherapy
    Table 4. Key Players of Gene therapy
    Table 5. Key Players of Molecular biotechnology
    Table 6. Global Glioblastoma Multiforme Treatment (GBM) Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Glioblastoma Multiforme Treatment (GBM) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Glioblastoma Multiforme Treatment (GBM) Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Glioblastoma Multiforme Treatment (GBM) Market Share by Region (2017-2022)
    Table 10. Global Glioblastoma Multiforme Treatment (GBM) Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Glioblastoma Multiforme Treatment (GBM) Market Share by Region (2023-2028)
    Table 12. Glioblastoma Multiforme Treatment (GBM) Market Trends
    Table 13. Glioblastoma Multiforme Treatment (GBM) Market Drivers
    Table 14. Glioblastoma Multiforme Treatment (GBM) Market Challenges
    Table 15. Glioblastoma Multiforme Treatment (GBM) Market Restraints
    Table 16. Global Glioblastoma Multiforme Treatment (GBM) Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Glioblastoma Multiforme Treatment (GBM) Market Share by Players (2017-2022)
    Table 18. Global Top Glioblastoma Multiforme Treatment (GBM) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glioblastoma Multiforme Treatment (GBM) as of 2021)
    Table 19. Ranking of Global Top Glioblastoma Multiforme Treatment (GBM) Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Glioblastoma Multiforme Treatment (GBM) Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Glioblastoma Multiforme Treatment (GBM) Product Solution and Service
    Table 23. Date of Enter into Glioblastoma Multiforme Treatment (GBM) Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Type (2017-2022)
    Table 27. Global Glioblastoma Multiforme Treatment (GBM) Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Type (2023-2028)
    Table 29. Global Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Application (2017-2022)
    Table 31. Global Glioblastoma Multiforme Treatment (GBM) Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Application (2023-2028)
    Table 33. North America Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Merck Company Detail
    Table 44. Merck Business Overview
    Table 45. Merck Glioblastoma Multiforme Treatment (GBM) Product
    Table 46. Merck Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2017-2022) & (US$ Million)
    Table 47. Merck Recent Development
    Table 48. Teva Pharmaceutical Company Detail
    Table 49. Teva Pharmaceutical Business Overview
    Table 50. Teva Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Product
    Table 51. Teva Pharmaceutical Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2017-2022) & (US$ Million)
    Table 52. Teva Pharmaceutical Recent Development
    Table 53. Arbor Pharmaceuticals Company Detail
    Table 54. Arbor Pharmaceuticals Business Overview
    Table 55. Arbor Pharmaceuticals Glioblastoma Multiforme Treatment (GBM) Product
    Table 56. Arbor Pharmaceuticals Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2017-2022) & (US$ Million)
    Table 57. Arbor Pharmaceuticals Recent Development
    Table 58. Sun Pharmaceutical Company Detail
    Table 59. Sun Pharmaceutical Business Overview
    Table 60. Sun Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Product
    Table 61. Sun Pharmaceutical Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2017-2022) & (US$ Million)
    Table 62. Sun Pharmaceutical Recent Development
    Table 63. Roche Company Detail
    Table 64. Roche Business Overview
    Table 65. Roche Glioblastoma Multiforme Treatment (GBM) Product
    Table 66. Roche Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2017-2022) & (US$ Million)
    Table 67. Roche Recent Development
    Table 68. Research Programs/Design for This Report
    Table 69. Key Data Information from Secondary Sources
    Table 70. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Glioblastoma Multiforme Treatment (GBM) Market Share by Type: 2021 VS 2028
    Figure 2. Chemotherapy Features
    Figure 3. Radiotherapy Features
    Figure 4. Gene therapy Features
    Figure 5. Molecular biotechnology Features
    Figure 6. Global Glioblastoma Multiforme Treatment (GBM) Market Share by Application in 2021 & 2028
    Figure 7. Hospital & Clinic Case Studies
    Figure 8. ASCs Case Studies
    Figure 9. Others Case Studies
    Figure 10. Glioblastoma Multiforme Treatment (GBM) Report Years Considered
    Figure 11. Global Glioblastoma Multiforme Treatment (GBM) Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Glioblastoma Multiforme Treatment (GBM) Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Glioblastoma Multiforme Treatment (GBM) Market Share by Region: 2021 VS 2028
    Figure 14. Global Glioblastoma Multiforme Treatment (GBM) Market Share by Players in 2021
    Figure 15. Global Top Glioblastoma Multiforme Treatment (GBM) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glioblastoma Multiforme Treatment (GBM) as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Glioblastoma Multiforme Treatment (GBM) Revenue in 2021
    Figure 17. North America Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Glioblastoma Multiforme Treatment (GBM) Market Share by Country (2017-2028)
    Figure 19. United States Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Glioblastoma Multiforme Treatment (GBM) Market Share by Country (2017-2028)
    Figure 23. Germany Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Glioblastoma Multiforme Treatment (GBM) Market Share by Region (2017-2028)
    Figure 31. China Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Glioblastoma Multiforme Treatment (GBM) Market Share by Country (2017-2028)
    Figure 39. Mexico Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Glioblastoma Multiforme Treatment (GBM) Market Share by Country (2017-2028)
    Figure 43. Turkey Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Merck Revenue Growth Rate in Glioblastoma Multiforme Treatment (GBM) Business (2017-2022)
    Figure 46. Teva Pharmaceutical Revenue Growth Rate in Glioblastoma Multiforme Treatment (GBM) Business (2017-2022)
    Figure 47. Arbor Pharmaceuticals Revenue Growth Rate in Glioblastoma Multiforme Treatment (GBM) Business (2017-2022)
    Figure 48. Sun Pharmaceutical Revenue Growth Rate in Glioblastoma Multiforme Treatment (GBM) Business (2017-2022)
    Figure 49. Roche Revenue Growth Rate in Glioblastoma Multiforme Treatment (GBM) Business (2017-2022)
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
Teva Pharmaceutical
Arbor Pharmaceuticals
Sun Pharmaceutical
Roche
Frequently Asked Questions
Glioblastoma Multiforme Treatment (GBM) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Glioblastoma Multiforme Treatment (GBM) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Glioblastoma Multiforme Treatment (GBM) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Gonorrhea Diagnostic

Gonorrhea Diagnostic market is segmented by players, region (country), by Type and by Application ... Read More

Gynecological Device

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More